Your browser doesn't support javascript.
loading
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Thudium Mueller, Karen; Grupp, Stephan A; Maude, Shannon L; Levine, John E; Pulsipher, Michael A; Boyer, Michael W; August, Keith J; Myers, G Doug; Tam, Constantine S; Jaeger, Ulrich; Foley, Stephen Ronan; Borchmann, Peter; Schuster, Stephen J; Waller, Edmund K; Awasthi, Rakesh; Potthoff, Bernd; Warren, Andy; Waldron, Edward R; McBlane, Fraser; Chassot-Agostinho, Andrea; Laetsch, Theodore W.
Afiliação
  • Thudium Mueller K; Novartis Institutes for BioMedical Research, East Hanover, NJ.
  • Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Maude SL; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Levine JE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Pulsipher MA; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Boyer MW; Department of Pediatrics, University of Michigan, Ann Arbor, MI.
  • August KJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Myers GD; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Tam CS; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, UT.
  • Jaeger U; Children's Mercy Hospital, Kansas City, MO.
  • Foley SR; Children's Mercy Hospital, Kansas City, MO.
  • Borchmann P; Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.
  • Schuster SJ; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Waller EK; Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Awasthi R; Department of Haematology and Oncology, University Hospital of Cologne, Cologne, Germany.
  • Potthoff B; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Warren A; Bone Marrow and Stem Cell Transplant Center, Winship Cancer Institute, Emory University, Atlanta, GA.
  • Waldron ER; Novartis Institutes for BioMedical Research, East Hanover, NJ.
  • McBlane F; Novartis Pharma AG, Basel, Switzerland.
  • Chassot-Agostinho A; Salt River Integrated Bioanalysis GmbH, Basel, Switzerland.
  • Laetsch TW; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
Blood Adv ; 5(23): 4980-4991, 2021 12 14.
Article em En | MEDLINE | ID: mdl-34432863
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Animals / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Animals / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article